Erste Asset Management’s Twist Bioscience TWST Stock Holding History

Erste Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,100	Closed	-$448K	–	603
2022 Q4	$448K	Hold	19,100	–	–	0.01%	433
2022 Q3	$683K	Hold	19,100	–	–	0.02%	387
2022 Q2	$664K	Buy	19,100 +8,000	+72%	+$283K	0.01%	396
2022 Q1	$558K	Buy	11,100 +6,100	+122%	+$338K	0.01%	427
2021 Q4	$377K	Hold	5,000	–	–	0.01%	447
2021 Q3	$522K	Hold	5,000	–	–	0.01%	400
2021 Q2	$673K	Hold	5,000	–	–	0.01%	378
2021 Q1	$549K	Sell	5,000 -6,900	-58%	-$1.05M	0.01%	382
2020 Q4	$1.65M	Buy	+11,900	New	+$1.32M	0.05%	293

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Erste Asset Management's TWST Position: Q1 2023 in Review

Erste Asset Management sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 19,100 shares — an estimated $448K sold.

Erste Asset Management first reported a position in TWST in Q4 2020 and held it in 9 quarters. The position peaked at $1.65M in Q4 2020. 201 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

Erste Asset Management reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
Erste Asset Management sold 19,100 Twist Bioscience shares in Q1 2023, an estimated $448K.
Erste Asset Management first reported a position in Twist Bioscience in Q4 2020 and held it in 9 quarters.
Erste Asset Management's Twist Bioscience position peaked at $1.65M in Q4 2020.
201 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Erste Asset Management's 13F filing for Q1 2023, filed 26 Nov 2024.